INMD Stock Overview
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
InMode Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$20.76 |
52 Week High | US$48.25 |
52 Week Low | US$18.57 |
Beta | 2.17 |
1 Month Change | -8.95% |
3 Month Change | -9.50% |
1 Year Change | -30.15% |
3 Year Change | -43.39% |
5 Year Change | n/a |
Change since IPO | 205.97% |
Recent News & Updates
InMode: Q4 Earnings Beat Not Enough - Macro Outlook Key To Buy Signal
Feb 16InMode: Take The Plunge Before It Goes Into Beast Mode
Feb 04Is InMode Ltd. (NASDAQ:INMD) Trading At A 49% Discount?
Jan 30Recent updates
InMode: Q4 Earnings Beat Not Enough - Macro Outlook Key To Buy Signal
Feb 16InMode: Take The Plunge Before It Goes Into Beast Mode
Feb 04Is InMode Ltd. (NASDAQ:INMD) Trading At A 49% Discount?
Jan 30InMode: Good Margin Of Safety At Current Levels
Jan 21Potential Upside For InMode Ltd. (NASDAQ:INMD) Not Without Risk
Dec 18InMode (NASDAQ:INMD) Will Want To Turn Around Its Return Trends
Oct 16If EPS Growth Is Important To You, InMode (NASDAQ:INMD) Presents An Opportunity
Jul 31InMode (NASDAQ:INMD) Knows How To Allocate Capital
Jul 16InMode Ltd. (NASDAQ:INMD) Shares Could Be 41% Below Their Intrinsic Value Estimate
May 22Capital Investment Trends At InMode (NASDAQ:INMD) Look Strong
Apr 05An Intrinsic Calculation For InMode Ltd. (NASDAQ:INMD) Suggests It's 33% Undervalued
Feb 20InMode (NASDAQ:INMD) Is Aiming To Keep Up Its Impressive Returns
Jan 03InMode (NASDAQ:INMD) Ticks All The Boxes When It Comes To Earnings Growth
Dec 01Is There An Opportunity With InMode Ltd.'s (NASDAQ:INMD) 48% Undervaluation?
Nov 12InMode gains after setting stronger-than-anticipated Q3 pre-results, guidance
Oct 13InMode: Recession May Kill Consumer Demand
Oct 05InMode: Aesthetic Tech Company Targeting Paradigm 2
Sep 13InMode Is On Its Launching Pad Again
Sep 02InMode (NASDAQ:INMD) Could Become A Multi-Bagger
Aug 23Is Now The Time To Put InMode (NASDAQ:INMD) On Your Watchlist?
Aug 05InMode: Alpha Long-Term Growth - Playing The Insurance Game Next
Aug 02InMode Set To Outperform Going Forward, We Join The Bull Camp
Jul 25InMode stock gains on guiding Q2 earnings above consensus; Raises FY2022 revenue outlook
Jul 12InMode: Prettier Again
Jun 27InMode Stock: Hidden Opportunity
Jun 03InMode: Management Could Repurchase 25% Of Their Float
May 19Why We Like The Returns At InMode (NASDAQ:INMD)
May 17Is There Now An Opportunity In InMode Ltd. (NASDAQ:INMD)?
Apr 25Is InMode Ready To Explode?
Mar 23Here's Why I Think InMode (NASDAQ:INMD) Is An Interesting Stock
Mar 18An Intrinsic Calculation For InMode Ltd. (NASDAQ:INMD) Suggests It's 39% Undervalued
Mar 03InMode: Reiterate Hold Rating After FY21 Results
Feb 15InMode: Initiates Coverage With Hold Rating Prior To FY21 Earnings Release
Feb 07Why You Should Care About InMode's (NASDAQ:INMD) Strong Returns On Capital
Feb 05InMode Stock: Down 50% From Its High - It's Time To Buy
Jan 18InMode: Good Company At A Beautiful Price
Jan 09Is InMode Ltd. (NASDAQ:INMD) Potentially Undervalued?
Jan 06Why InMode Looks Good After Falling From $100
Dec 14Here's Why We Think InMode (NASDAQ:INMD) Is Well Worth Watching
Dec 07Shareholder Returns
INMD | US Medical Equipment | US Market | |
---|---|---|---|
7D | -3.6% | -1.5% | -0.1% |
1Y | -30.1% | 12.2% | 28.4% |
Return vs Industry: INMD underperformed the US Medical Equipment industry which returned 12.2% over the past year.
Return vs Market: INMD underperformed the US Market which returned 28.4% over the past year.
Price Volatility
INMD volatility | |
---|---|
INMD Average Weekly Movement | 6.7% |
Medical Equipment Industry Average Movement | 8.0% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: INMD's share price has been volatile over the past 3 months.
Volatility Over Time: INMD's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 581 | Moshe Mizrahy | https://www.inmodemd.com |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation.
InMode Ltd. Fundamentals Summary
INMD fundamental statistics | |
---|---|
Market cap | US$1.75b |
Earnings (TTM) | US$197.92m |
Revenue (TTM) | US$492.05m |
8.8x
P/E Ratio3.6x
P/S RatioIs INMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
INMD income statement (TTM) | |
---|---|
Revenue | US$492.05m |
Cost of Revenue | US$80.71m |
Gross Profit | US$411.34m |
Other Expenses | US$213.42m |
Earnings | US$197.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 2.35 |
Gross Margin | 83.60% |
Net Profit Margin | 40.22% |
Debt/Equity Ratio | 0% |
How did INMD perform over the long term?
See historical performance and comparison